AstraZeneca ticks up as FDA finally approves new drug
Shares in drug maker AstraZeneca (AZN) rose had risen by 2.52% to 5,373p at 1100 BST after the US Food and Drug Administration approved Lokelma, which is designed to treat high blood potassium levels.